Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?27.12

?27.12

 
WKN: 856244 / Symbol: DBD / Name: Diebold / Stock / Computers, Phones & Household Electronics / Small Cap /
Latest predictions
€27.12
10.11.23
-
buy
09.07.23
0.00%
01.07.23
0.00%
14.05.23
-33.23%
06.05.23
-42.30%
Your prediction

Diebold Inc. Stock

Currently there is a rather negative sentiment for Diebold Inc. with 1 Buy predictions and 4 Sell predictions..
However, we have a potential of 12117.19% for Diebold Inc. as the target price of 27 € is above the current price of 0.22 €.

Pros and Cons of Diebold Inc. in the next few years

Pros
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Diebold Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Diebold Inc. - - - - - - -
Key Tronic Corp. 1.020% -4.327% -7.870% -34.754% 5.851% -30.783% -16.439%
Synaptics Inc. -0.550% 3.954% -7.828% 3.980% -21.132% -28.179% -
Wayside Technology Group 0.820% 0.000% -1.600% 57.692% 23.992% 207.500% 478.334%

Comments

Prediction Buy
Perf. (%) -
Target price 27.121
Change
Ends at 10.11.24

Diebold Nixdorf, Incorporated (NYSE: DBD) was upgraded by analysts at DA Davidson from a "neutral" rating to a "buy" rating. They now have a $29.00 price target on the stock, up previously from $25.00.
Ratings data for DBD provided by MarketBeat
Show more

Diebold Nixdorf, Incorporated (NYSE: DBD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for DBD provided by MarketBeat
Show more

Diebold Nixdorf, Incorporated (NYSE: DBD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for DBD provided by MarketBeat
Show more